These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18468835)

  • 1. Association of p53 polymorphisms and colorectal cancer: modulation of risk and progression.
    Mammano E; Belluco C; Bonafé M; Olivieri F; Mugianesi E; Barbi C; Mishto M; Cosci M; Franceschi C; Lise M; Nitti D
    Eur J Surg Oncol; 2009 Apr; 35(4):415-9. PubMed ID: 18468835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
    Franeková M; Zúbor P; Stanclová A; Dussan CA; Bohusová T; Galo S; Dobrota D; Kajo K; Péc M; Racay P
    Neoplasma; 2007; 54(2):155-61. PubMed ID: 17319790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of p53 codon 72 polymorphism with liver metastases of colorectal cancers positive for p53 overexpression.
    Zhu ZZ; Liu B; Wang AZ; Jia HR; Jin XX; He XL; Hou LF; Zhu GS
    J Zhejiang Univ Sci B; 2008 Nov; 9(11):847-52. PubMed ID: 18988302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
    De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
    Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer.
    Csejtei A; Tibold A; Varga Z; Koltai K; Ember A; Orsos Z; Feher G; Horvath OP; Ember I; Kiss I
    Anticancer Res; 2008; 28(3B):1917-22. PubMed ID: 18630481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of p53 gene in Jordanian population and possible associations with breast cancer and lung adenocarcinoma.
    Mahasneh AA; Abdel-Hafiz SS
    Saudi Med J; 2004 Nov; 25(11):1568-73. PubMed ID: 15573180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
    Wang AZ; Zhu ZZ; Cong WM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
    Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
    Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype.
    Perfumo C; Bonelli L; Menichini P; Inga A; Gismondi V; Ciferri E; Percivale P; Bianchi Scarrà G; Nasti S; Fronza G; Varesco L
    Digestion; 2006; 74(3-4):228-35. PubMed ID: 17374954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients.
    Bau DT; Tsai MH; Lo YL; Hsu CM; Tsai Y; Lee CC; Tsai FJ
    Anticancer Res; 2007; 27(3B):1559-64. PubMed ID: 17595776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
    Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
    Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [p53 gene intron 7 polymorphism and its association with oral neoplasms].
    Li YQ; Li YL; Gu QH; Ye AH; Wu TS
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Sep; 40(5):386-9. PubMed ID: 16255923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
    Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
    Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.
    Sameer AS; Shah ZA; Syeed N; Banday MZ; Bashir SM; Bhat BA; Siddiqi MA
    Genet Mol Res; 2010 Apr; 9(2):651-60. PubMed ID: 20449797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
    Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
    Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
    Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
    J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
    Dimberg J; Hugander A; Löfgren S; Wågsäter D
    Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of specific p53 polymorphisms with keratosis in individuals exposed to arsenic through drinking water in West Bengal, India.
    De Chaudhuri S; Mahata J; Das JK; Mukherjee A; Ghosh P; Sau TJ; Mondal L; Basu S; Giri AK; Roychoudhury S
    Mutat Res; 2006 Oct; 601(1-2):102-12. PubMed ID: 16930632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 codon 72 polymorphism and HPV status in lung cancer.
    Buyru N; Altinisik J; Isin M; Dalay N
    Med Sci Monit; 2008 Sep; 14(9):CR493-7. PubMed ID: 18758421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.